. Correction to: Randomized trial of First-Line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-Mutated Non-Small cell lung cancer. J Natl Cancer Inst 2023 May 18:djad084. doi: 10.1093.
PMID: 37203415